Articles related to Dapagliflozin; glycemic control; chronic kidney disease; glomerular filtration r


Dapagliflozin Approved for Prevention of CKD Progression
Dapagliflozin Approved for Prevention of CKD Progression

Chronic kidney disease patients with protein in their urine have a higher risk of dying than the general population, and diabetes is currently the number one cause of the disease in the United States.

Read More
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: